郭彤：eCLInical革新与趋势
A remarkable transformation is emerging of the way the biopharmaceutical industry conducts global CLInical trials. Coupled with this much needed evolution are new challenges specific to the increasing role that information technology will play to enable the new CLInical development landscape. Of the many challenges facing the biopharmaceutical industry today, the critical need for greater operational efficiency in CLInical drug development is paramount. In the past decades, we have seen many technology advancements, including CLInical trial management systems (CTMS), electronic trial master files (eTMFs), open standards, mobile access, tablets, and cloud computing. This presentation will discuss the above challenges and review the new trends of technology enabled solutions in CLInical research. .
符合美国CLIA标准的高通量测序临床试验研发案例分享
孙洪业博士现场分享了归国后在药明康德基因中心组建的努力。包括该中心如何利用高效、整合地运用基因组学最新技术，推动药物研发、临床试验以及个性化治疗事业进步。
孙博士就进行中的3个临床相关项目做了分享。
符合美国CLIA标准的高通量测序临床试验研发案例分享
视频内容主要包括：药明康德基因中心的使命，基因中心的成就和服务范畴，基因组学能力建设：顶级平台，进行中的临床相关项目等。
Pre-CLInical In Vivo Imaging Solutions from PerkinElmer
PerkinElmer offers a comprehensive portfolio of pre-CLInical in vivo imaging systems and reagents. Find out more at http://bit.ly/1mnyvwF. Our pre-CLInical imaging instruments include our highly published (over 4000 citations) IVIS Optical imaging systems, Quantum FX microCT which delivers high quality images at an x-ray dose low enough for longitudinal studies, and x-ray systems. We also offer a large portfolio of in vivo imaging reagents for most areas of research including cancer, infectious disease, stem cell, inflammation, toxicology/drug safety and more.